secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001493152-23-019987
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce completes $7M offering, believes it meets Nasdaq equity requirement
---------------------------------------------------------------------------

- Raised ~$7M gross via public offering of common stock and warrants on May 12, 2023.
- Previously notified of non-compliance with Nasdaq's $2.5M stockholders' equity minimum.
- Hearings Panel granted extension to June 12, 2023; company now believes it satisfies the Rule.
- Awaiting formal Nasdaq confirmation of compliance status.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223019987/0001493152-23-019987-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223019987/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019987

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer